BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 35704741)

  • 1. Surveillance Study of Epidemiology, Antifungal Susceptibility and Risk Factors of Invasive Candidiasis in Critically ill Patients.
    Wang B; Wang Y; Zhang L; Lu F; Zhang M; Xu Y
    Clin Lab; 2022 Jun; 68(6):. PubMed ID: 35704741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
    Karabıçak N; Alem N
    Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of the prevalence, antibiotic susceptibility, and genotypic characterization of invasive candidiasis in a teaching hospital in China between 2006 to 2011.
    Li F; Wu L; Cao B; Zhang Y; Li X; Liu Y
    BMC Infect Dis; 2013 Jul; 13():353. PubMed ID: 23899244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
    Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
    Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and Antifungal Susceptibility of
    Badiee P; Boekhout T; Haddadi P; Mohammadi R; Ghadimi-Moghadam A; Soltani J; Zarei Mahmoudabadi A; Ayatollahi Mousavi SA; Najafzadeh MJ; Diba K; Salimi-Khorashad AR; Amin Shahidi M; Ghasemi F; Jafarian H
    Microbiol Spectr; 2022 Dec; 10(6):e0245322. PubMed ID: 36445122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-Year National Surveillance of Invasive Candidiasis: Species Distribution and Azole Susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study.
    Xiao M; Sun ZY; Kang M; Guo DW; Liao K; Chen SC; Kong F; Fan X; Cheng JW; Hou X; Zhou ML; Li Y; Yu SY; Huang JJ; Wang H; Xu YC;
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antifungal susceptibilities of Candida isolates from patients with invasive candidiasis in Kuala Lumpur Hospital, Malaysia.
    Amran F; Aziz MN; Ibrahim HM; Atiqah NH; Parameswari S; Hafiza MR; Ifwat M
    J Med Microbiol; 2011 Sep; 60(Pt 9):1312-1316. PubMed ID: 21459913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Epidemiology, Antifungal Susceptibility, and Virulence Evaluation of
    Chen J; Hu N; Xu H; Liu Q; Yu X; Zhang Y; Huang Y; Tan J; Huang X; Zeng L
    Front Cell Infect Microbiol; 2021; 11():721439. PubMed ID: 34604110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro activity of voriconazole and other antifungal agents against clinical isolates of 138 Candida spp].
    Ricciardi AM; Ricciardi R; Danzi M; Mungiguerra M; Pisano L; Marino A
    Infez Med; 2009 Mar; 17(1):24-7. PubMed ID: 19359821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive candidiasis in intensive care units in China: in vitro antifungal susceptibility in the China-SCAN study.
    Liu W; Tan J; Sun J; Xu Z; Li M; Yang Q; Shao H; Zhang L; Liu W; Wan Z; Cui W; Zang B; Jiang D; Fang Q; Qin B; Qin T; Li W; Guo F; Liu D; Guan X; Yu K; Qiu H; Li R;
    J Antimicrob Chemother; 2014 Jan; 69(1):162-7. PubMed ID: 24004860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.
    Wang H; Xu YC; Hsueh PR
    Future Microbiol; 2016 Oct; 11():1461-1477. PubMed ID: 27750452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
    Panizo MM; Reviákina V; Dolande M; Selgrad S
    Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The patterns of colonization and antifungal susceptibility of Candida, isolated from preterm neonates in Khorramabad, South West of Iran.
    Kooshki P; Rezaei-Matehkolaei A; Mahmoudabadi AZ
    J Mycol Med; 2018 Jun; 28(2):340-344. PubMed ID: 29530715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility of Candida spp. to fluconazole, itraconazole and voriconazole and the correlation between triazoles susceptibility: Results from a five-year study.
    Lei J; Xu J; Wang T
    J Mycol Med; 2018 Jun; 28(2):310-313. PubMed ID: 29685520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro Antifungal Activity of Azoles and Other Antifungal Agents Against Pathogenic Yeasts from Vulvovaginal Candidiasis in China.
    Kan S; Song N; Pang Q; Mei H; Zheng H; Li D; Cui F; Lv G; An R; Li P; Xiong Z; Fan S; Zhang M; Chen Y; Qiao Q; Liang X; Cui M; Li D; Liao Q; Li X; Liu W
    Mycopathologia; 2023 Apr; 188(1-2):99-109. PubMed ID: 36378354
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Wang B; He X; Lu F; Li Y; Wang Y; Zhang M; Huang Y; Xia J
    Front Public Health; 2021; 9():779590. PubMed ID: 34858938
    [No Abstract]   [Full Text] [Related]  

  • 19. Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study.
    Mokaddas EM; Al-Sweih NA; Khan ZU
    J Med Microbiol; 2007 Feb; 56(Pt 2):255-259. PubMed ID: 17244809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and genotypic characterization of virulence markers and antifungal susceptibility of oral Candida species from diabetic and non-diabetic hemodialysis patients.
    Mohammadi F; Charkhchian M; Mirzadeh M
    BMC Oral Health; 2023 May; 23(1):261. PubMed ID: 37143002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.